Publication | Closed Access

VicTORia: a randomised phase II study to compare vinorelbine in combination with the mTOR inhibitor everolimus versus vinorelbine monotherapy for second-line chemotherapy in advanced HER2-negative breast cancer

Breast OncologyOncologyMedicineVersus Vinorelbine MonotherapyBreast CancerPharmacotherapyMtor InhibitorAnti-cancer AgentCancer TreatmentPharmacologyMolecular OncologySecond-line Chemotherapy